New York City-based pharmaceutical company Pfizer Inc is planning on investing $600 million in biotechnology and other emerging growth companies through Pfizer Ventures. About 25 percent of the funding will focus on neuroscience.
SUBSCRIBE
Biohealth Innovation
Founding Member of
